UK launch for progressive multiple sclerosis mega-trial
7th May 2021
The MS Society had announced that a world-first mega-trial for progressive multiple sclerosis (MS) will be launched in the UK later this year.
According to the charity, Octopus (named for its many arms) is “a revolutionary clinical trial that will transform the way treatments for progressive MS are tested – and could deliver desperately needed new options up to three times faster”.
Octopus will test several drugs – as opposed to just one – against a placebo at the same time, and will also combine what would normally be two consecutive trial phases into one, potentially rapidly speeding up the development of new treatments.
A new analysis of brain MRI scans of people with multiple sclerosis (MS) reveals that individual cases fall into one of three newly discovered MS subtypes.
3 Distinct Subtypes of Multiple Sclerosis Have Been Identified in Brain Scans
7 APRIL 2021
Symptoms might come and go. Speech could falter. There may be pain, or perhaps loss of senses. Almost certainly, though, a diagnosis of MS brings with itself a future full of uncertainty. Now, we have a new tool that might help to alleviate the latter.
Getting an accurate prognosis of MS early on can help people better prepare for what s to come, but clinical testing can t currently tell clinicians whether or not a specific case will respond well to a particular treatment in the future.
A new study conducted by an international team of researchers used artificial intelligence to identify three relatively distinct subtypes of anatomy among brain scans taken from 6,322 patients with MS.